Beltran Pedro — SEC Form 4 filings

SEC reporting owner CIK 2058152. 5 Form 4 filings on record with FilingPulse; latest filed 2026-07-06.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2025-08-28 to 2026-07-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BridgeBio Oncology Therapeutics, Inc. (BBOT)President and CEO, Director56

Form 4 filings — Beltran Pedro

FiledFormIssuerReported transactionsSource
2026-07-064BridgeBio Oncology Therapeutics, Inc. (BBOT)Tax withholding (F): 1,047 @ $7.80EDGAR
2026-05-124BridgeBio Oncology Therapeutics, Inc. (BBOT)Grant/award (A): 1,103,837 (derivative) @ $0EDGAR
2026-05-054BridgeBio Oncology Therapeutics, Inc. (BBOT)Tax withholding (F): 1,047 @ $9.03EDGAR
2026-03-124BridgeBio Oncology Therapeutics, Inc. (BBOT)Grant/award (A): 46,670 @ $0 · Grant/award (A): 210,000 (derivative) @ $0EDGAR
2025-08-284BridgeBio Oncology Therapeutics, Inc. (BBOT)Grant/award (A): 357,177 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2058152 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →